Juno Pharmaceuticals Canada
Greg LaMorre is a seasoned professional in supply chain management and operations within the pharmaceutical industry, currently serving as the Director of CMO, Supply Chain & Vendor Relations at Juno Pharmaceuticals Canada since December 2019. LaMorre has extensive experience managing comprehensive supply chain functions, vendor relationships, and customer service, having previously held roles such as Supply Chain Manager at a generic pharmaceutical company and Inventory Control Manager at Taro Pharmaceuticals Canada. LaMorre's background includes significant contributions to inventory management, production scheduling, and process optimization at multiple organizations, including Actavis Pharmaceuticals, Eben Graphics, and Swiss Herbal Remedies. Educational achievements include a Bachelor of Business Administration from St. Francis Xavier University and a Business Leadership Diploma from Queen's University, supplemented by a Purchasing Diploma from PMAC.
This person is not in any teams
This person is not in any offices
Juno Pharmaceuticals Canada
Juno Pharmaceuticals Canada sources, develops, and delivers life saving specialized pharmaceutical products for Canadian patients. Our colleagues work with trusted partners to co-develop novel drug delivery mechanisms that satisfy untapped market demand, first to market generic products, biosimilar offerings, and patent challenge strategies. Juno’s portfolio consists of both branded and generic drug assets in multiple presentation forms including injectable drugs (vials, amps, & pre filled syringes), complex biosimilars, ophthalmic products, oral does tablets and capsules, prescription dermatology topicals, and other unique dosage systems. Our team have deep roots into the Canadian hospital space, retail pharmacy market, specialty channels, and a robust B2B platform. In addition, Juno Canada has recently embarked with product sourcing in the animal health space and remain focused on opening new delivery channels and customer groups to facilitate supply for Canadian patients. Juno is proud to supply 5 molecules deemed medically necessary by the World Health Organization on their critically essential medications list, and we are actively pursuing export opportunities to countries in need of our critical medications. To learn more about Juno Pharmaceuticals Canada please contact us at communications@junopharm.com For sales enquiries contact us at sales@junopharm.com